跳至主要内容
临床试验/CTRI/2020/12/030129
CTRI/2020/12/030129尚未招募未知

Evaluation of Molecular signature of Pregnancy Associated Breast Cancer

Tata Memorial Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1) Patients with histologically confirmed breast cancer who are pregnant.
  • 2) Or Patients who got diagnosed within 1 year of last pregnancy with histologically confirmed breast cancer.
  • 3) Informed consent for data collection (for prospective participants only)
  • 4) For retrospective participants an informed consent is not required as long as the data are anonymously captured.

排除标准

  • 1) Unwilling to participate.
  • 2) Not able to give valid informed consent.
  • 3) In retrospective registry, where records not available

研究者

相似试验